Recently, The UK government’s Office for Product Safety and Standards (OPSS) is actively seeking data from the beauty industry regarding the safety of certain cosmetic ingredients as part of its ongoing commitment to consumer protection. Specifically, the OPSS has identified prostaglandins, alpha- and beta-arbutin, and vitamin A as key ingredients of concern.
Prostaglandins and their analogs, commonly used in eyelash growth products, have gained popularity in the UK market. However, due to their potency and proximity to sensitive areas like the eyes, the OPSS is calling for comprehensive research into their safety. Previous concerns raised by various scientific bodies and regulatory agencies have prompted this inquiry.
Alpha- and beta-arbutin, which serve as antioxidants and skin conditioning agents, are also under scrutiny. The OPSS has expressed worries about their potential degradation into hydroquinone under standard storage conditions. Hydroquinone, a known carcinogen and strong skin sensitizer, is heavily regulated, with strict limitations on its use in cosmetic products.
Vitamin A derivatives, such as retinol and retinyl palmitate, are included for their sought-after anti-aging and antioxidant benefits. However, given that food and dietary supplements are significant sources of vitamin A, the OPSS cautions that the cumulative exposure from cosmetics could exceed safe levels, posing a potential risk to human health.
To address these issues, the OPSS invites contributions from a wide range of stakeholders, including academia, manufacturers, and consumer organizations, until April 30, 2025. The forthcoming safety assessments will be guided by a default body weight assumption of 70 kg for adults, as set by the Scientific Advisory Group on Chemical Safety.
